## 

## 



|||Page|Page||
|---|---|---|---|---|
|Report ofthe Trustees||I|to|3|
|Independent<br>Examiner's|Report||||
|Statement ofFinancial|Activities||||
|Balance Sheet|||||
|Cash Flow Statement|||||
|Notes to the Cash Flow|Statement||||
|Notes to the Financial Statements||9|to|19|
|Detailed Statement of Financial Activities|||20||





## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 



## 

## 



## 

## 

||||||2021|2020|
|---|---|---|---|---|---|---|
||||Unrestricted|Restricted|Total|Total|
||||fund|funds|funds|funds|
|||Notes|||||
|INCOME AND ENDOWMENTS FROM<br>Donations<br>and legaoies||2|298,731|77,745|376,476|1,244,695|
|Other trading activities<br>Investment<br>income||3<br>4|126&194<br>128|3,807|130,001<br>128|245,651<br>239|
|Total|||425&053|81,552|506,605|1,490,585|
|EXPENDITURE ON<br>Raising funds||5|56&768||56&768|187,304|
|Charitable<br>activities|||||||
|Medical equipment<br>costs<br>Other donations|||190<br>371&128|3,700<br>240,939|3&890<br>612,067|1,368,226|
|Other|||1,200||1&200|2,400|
|Total|||429,286|244,639|673,925|1,557,930|
|NET INCOME/(EXPENDITURE&)|||(4&233)|(163,087)|(167,320)|(67,345)|
|Transfers<br>between<br>funds||15|(72,298)|72&298|||
|Net movement<br>in funds|||(76,531)|(90,789)|(167420)|(67,345)|
|RECONCILIATION|OF I&UNDS||||||
|Total funds brought|fomvard||76,531|90,789|167&320|234„665|
|TOTAL FUNDS CARRIED FORWARD||||||167,320|





## 

|||||2021|2020|
|---|---|---|---|---|---|
|||Unrestricted|Restricted|Total|Total|
|||fund|funds|funds|firnds|
||Notes|||f.||
|CURRENT ASSETS<br>Debtors<br>Cash at bank|13|54,246<br>5,455||54,246<br>5,455|23,409<br>98J,541|
|||59,701||59,701|L 006,950|
|CREDITORS||||||
|Amounts<br>falling due within one year|14|(59,701)||(59,701)|(839,630)|
|NET CURRENT ASSETS|||||167,320|
|TOTAL ASSETSLESS CURRENT<br>LIABILITIES|||||167,320|
|NET ASSETS|||||167,320|
|FUNDS<br>Unrestricted<br>funds<br>Restricted funds|15||||76,531<br>90,789|
||||||167,320|



## 




## 

## 

## 

||||2021|2020|
|---|---|---|---|---|
|||Notes|g|6|
|Cash flows from operating<br>activities<br>Cash generated<br>from operations||I|(976,214)|354,424|
|Net cash (used in)/provided|by operating|activities|(976,214)|354,424|
|Cash flows from investing<br>Interest received|activities||128|239|
|Net cash provided<br>by investing<br>activities|||128|239|
|Change in cash and cash <br>the reporting<br>period|equivalents|in|(976,086)|354,663|
|Cash and cash equivalents<br>beginning<br>ofthe reporting|at the<br>period||9811541|626,878|
|Cash and cash equivalents<br>the reporting<br>period|at the end|of|5,455|98L543|





## 

||RECONCILIATION|RECONCILIATION|OF NKT EXPENDITURE TO NET CASH FLOW FROM OPERATING|OF NKT EXPENDITURE TO NET CASH FLOW FROM OPERATING|OF NKT EXPENDITURE TO NET CASH FLOW FROM OPERATING|OF NKT EXPENDITURE TO NET CASH FLOW FROM OPERATING|OF NKT EXPENDITURE TO NET CASH FLOW FROM OPERATING||
|---|---|---|---|---|---|---|---|---|
||ACTIVITIES||||||||
|||||||2021||2020|
||Net expenditure<br>for the reporting<br>Financial<br>Activities)||||period (as per the Statement of|(167,320)||(67,345)|
||Adjustments<br>for:<br>Interest received|||||(128)||(239)|
||Increase in debtors|||||(28,837)||(//, 345)|
||(Decrease)/increase|in creditors||||(779)929)||433,353|
||Net cash (used in)/provided|||by operations||(976,214)||354,424|
|2.|ANALYSIS OF CHANGES|||IN NET FUNDS|||||
||||||At I/I/21|Cash flow|At|31/12/21|
|||||||f,||5|
||Net cash||||||||
||Cash at bank||||981)541|(9765086)||5,455|
||||||981,541|(976,086)||5,455|
||Total||||981,541|(976&086)||5,455|





## 

## 

## 

## 

## 

## 



## 

## 

## 

||Further explanati|on|ofthe nature and purpose ofeach fund is|included<br>in the notes to the financial|statements.|
|---|---|---|---|---|---|
||DONATIONS|AND|LEGACIES|||
|||||2021|2020|
||Donations|||149,015|L242,676|
||Legacies|||227,461|2,079|
|||||376,476|L244,695|
|3.|OTHER TRADING ACTIVITIES|||||
|||||2021|2020|
|||||g||
||Fundraising<br>events|||130,001|245,657|
|4.|INVESTMENT INCOME|||||
|||||2021|2020|
|||||8|6|
||Deposit account interest|||128|239|
||RAISING IiUNDS|||||
||Raising donations||and legacies|2021|2020|
||||||6|
||Staffcosts|||34,834|12L594|
||Event expenses<br>Support costs|||8)521<br>13,413|30,347<br>35,363|
|||||56,768|IB7,304|





## 

## 

|6.|CHARITABLE A|CTIVITIES COSTS||||
|---|---|---|---|---|---|
|||||Grant||
|||||funding of||
|||||activities||
||||Direct|(see note||
||||Costs|7)|Totals|
||||5|5|5|
||Medical equipment|costs|190|3)700|3,890|
||Other donations|||612,067|612,067|
||||190|615,767|615,957|
|7.|GRANTS PAYABLE|||||
|||||2021|2020|
|||||5||
||Medical equipment|costs||3,700||
||Other donations|||612,067||
|||||615,767||
|8.|SUPPORT COSTS|||||
|||||Governance||
||||Finance|costs|Totals|
||||5|5|5|
||Raising donations<br>and legacies<br>Other resources expended||13,413|1,200|13)413<br>1,200|
||||13,413|1,200|14)613|



## 

## 



## 

|10.|STAIrF COSTS|||||2021|2020|
|---|---|---|---|---|---|---|---|
|||||||8||
||Wages and salaries|||||34,834|127,594|
|||||||34,834|12L594|
||The average monthly<br>number ofemployees|||during the year was as follows:||||
|||||||2021|2020|
||Fundraising<br>activities|||||3|4|
||No employees<br>received|emoluments|in excess off60,000.|||||
|11.|COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES|||||||
||||||Unrestricted|Restricted|Total|
||||||fund<br>8|funds<br>6|fundsf|
||INCOME AND ENDOWMENTS||FROM|||||
||Donations<br>and legacies||||120,574|1,124,121|1,244,695|
||Other trading activities<br>Investment<br>income||||220,562<br>239|25,089|245,651<br>239|
||Total||||341,375|1,149,210|1,490,585|
||EXPENDITURE ON|||||||
||Raising funds||||186,028|1,276|187,304|
||Charitable<br>activities|||||||
||Medical equipment<br>costs||||3,187|1,365,039|1,368,226|
||Other||||2,400||2,400|
||Total||||191,615|1,366,3 15|1,557,930|
||NET INCOME/(EXPENDITURE)||||149,760|(217,105)|(67,345)|
||Transfers<br>between<br>funds||||(122,013)|122,013||
||Net movement<br>in funds||||27,747|(95,092)|(67,345)|
||RECONCILIATION|OF FUNDS||||||
||Total funds brought|forward|||48,784|185,881|234,665|
||TOTAL FUNDS CARRIED FORWARD||||76,531|90,789|167,320|





## 

## 

|2.|INTANGIBLE FIXED ASSETS|||
|---|---|---|---|
||||Database|
||||cost|
||||5|
||COST|||
||At 1 January 2021<br>Disposals||7,800<br>(7,800)|
||At 31 December 2021|||
||AMORTISATION|||
||At<br>1 January 2021<br>Eliminated<br>on disposal||7,800<br>(7,800)|
||At 31December 2021|||
||NKT BOOI&VALUE|||
||At 31December 2021|||
||At 31December 2020|||
|13.|DEBTORS:AMOUNTS FALLING DUE WITHIN ONK YEAR|2021|2020|
|||8|8|
||Trade debtors<br>Gift aid due<br>prepayments<br>and accrued income|54,246|8,970<br>/0, 050<br>6,389|
|||54,246|25,409|
|14.|CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR|2021|2020|
|||8|6|
||Trade creditors<br>Other creditors|59,701|800,723<br>38,907|
|||59,701|839,630|





## 

## 

|MOVEMENT IN FUNDS||||||
|---|---|---|---|---|---|
||||Net|Transfers||
||||movement|between|At|
|||At I/1/21|in funds|funds|31/12/21|
|Unrestricted<br>funds||||||
|General fund||76,531|(4,233)|(72,298)||
|Restricted<br>funds||||||
|Closure||60,000|(61,000)|1,000||
|Radiology Elastography<br>2020 Iqoro Training Device||14,742<br>580|(37,050)<br>(9,562)|22,308<br>8,982||
|2020 Dri Oct Opthlmology||1,000|(1,000)|||
|HGF Fund||7,668|(7,668)|||
|Baby Resus|||135|(135)||
|Egg Deep Covid Emergency|Fund|6,740|(6,740)|||
|Andover||59|(59)|||
|2020 Biometry for Opthoamology|||(40&143)|40,143||
|||90,789|(163,087)|72,298||
|TOTAL FUNDS||1671320|(167,320)|||
|Net movement<br>in funds, included||in the above are as follows:||||
||||Incoming|Resources|Movement|
||||resources|expended|in funds|
|Unrestricted<br>funds||||||
|General fund|||425,053|(429,286)|(4,233)|
|Restricted funds||||||
|Closure||||(61)000)|(61,000)|
|Radiology Elastography<br>2020 Iqoro Training Device<br>2020 Dri Oct Opthlmology<br>HGF Fund|||25,450<br>2,038<br>2,000|(629500)<br>(11)600)<br>(3,000)<br>(7,668)|(37,050)<br>(9,562)<br>(1,000)<br>(7,668)|
|Baby Resus<br>Dig Deep Covid Emergency<br>Andover|Fund||135|(6,740)<br>(59)|135<br>(60740)<br>(59)|
|2020 Biometry for Opthoamology<br>2020 Hologic Horizon Scanner|||250<br>50,000|(40,393)<br>(50,000)|(40,143)|
|2021 Paceports|||1,679|(1,679)||
||||81,552|(244,639)|(163,087)|
|TOTAL FUNDS|||506,605|(673,925)|(167,320)|





## 

## 

|Comparatives<br>for movement|in funds|||||
|---|---|---|---|---|---|
||||Net|Transfers||
||||movement|between|At|
|||At 1/1/20|in funds|funds|31/12/20|
|||||6|6|
|Unrestricted<br>funds<br>General fund||48,784|149,760|(122,013)|76,531|
|Restricted funds<br>Closure<br>Radiology Elastography<br>Medical Photography<br>Microbiology<br>Maldi<br>Urology Prostate Fusion Sys<br>Colposcopy<br>Advanced<br>Resus||45,000<br>17<br>42,646<br>61,423<br>27,207|11,554<br>(43,813)<br>(50,000)<br>2,167<br>(38,070)|15,000<br>3,188<br>(17)<br>1,167<br>(11,423)<br>(2,167)<br>10,863|60,000<br>14,742|
|Heart Andover 27k<br>2020 Haemorrhoids<br>2020 Vascular Ultrasound||9,588|(9,588)<br>(8,990)<br>(21,306)|8,990<br>21,306||
|2020 Sleep Activity Monitor<br>2020 Tissue Viability SEM Scanner<br>2020 Feno Niox -Paediatrics|||(367)<br>15<br>95|367<br>(15)<br>(95)||
|2020 Patient Transfer Scale<br>2020 Larynogograph<br>2020 Iqoro Training Device<br>2020 Neurotox|||(40)<br>(1,670)<br>1,280<br>179|40<br>1,670<br>(700)<br>(179)|580|
|2020 Airvo 2 Optiflow<br>2020 Dri Oct Opthlmology<br>Luninometer<br>Pathology<br>HGF Fund<br>2020 Slide Scanner<br>Baby Resus<br>Dig Deep Covid Emergency<br>Andover|Fund||700<br>1,000<br>(4,378)<br>7,668<br>(66,725)<br>(1,600)<br>4,725<br>59|(700)<br>4,378<br>66,725<br>1,600<br>2,015|1,000<br>7,668<br>6,740<br>59|
|||185,881|(217,105)|122,013|90,789|
|TOTAL FUNDS||234,665|(67,345)||167,320|





## 

## 

## 

|Comparative<br>net movemen|t<br>i|n funds, included<br>in the|above are as follows:|||
|---|---|---|---|---|---|
||||Incoming|Resources|Movement|
||||resources|expended|in funds|
|||||g|g|
|Unrestricted<br>funds||||||
|General fund|||341,375|(191,615)|149,760|
|Restricted funds||||||
|Radiology<br>Ktastography<br>Microbiology<br>Maldi<br>Urology Prostate Fusion <br>Colposcopy<br>Advanced<br>Resus|Sys||7,916<br>3,025<br>2,167<br>20,646|3,638<br>(46,838)<br>(50,000)<br>(58,716)|11,554<br>(43,813)<br>(50,000)<br>2,167<br>(38,070)|
|Heart Andover 27k|||45|(9,633)|(9,588)|
|2020 Haemorrhoids|||2,010|(11,000)|(8,990)|
|2020 Vascular Ultrasound||||(21,306)|(21,306)|
|2020 Sleep Activity Monitor|||2,424|(2,791)|(367)|
|2020 Tissue Viability SEM Scanner|||15||15|
|2020 Droplet Hydration|System||3,500|(3,500)||
|2020 Feno Niox - Paediatrics|||16,770|(16,675)|95|
|2020 Patient Transfer Scale|||2,430|(2,470)|(40)|
|2020 Larynogograph<br>2020 Iqoro Training Device<br>2020 Neurotox|||2,480<br>1,280<br>2,216|(4,150)<br>(2,037)|(1,670)<br>1,280<br>179|
|2020 Airvo 2 Optiflow|||700||700|
|2020Dri Oct Opthlmology<br>Luninometer<br>Pathology<br>HGF Fund|||1,000<br>525<br>8,944|(4,903)<br>(1,276)|1,000<br>(4,378)<br>7,668|
|2020 Slide Scanner|||775|(67,500)|(66,725)|
|Baby Resus<br>Dig Deep Covid Emergency<br>Andover||Fund|1,070,283<br>59|(1,600)<br>(1,065,558)|(1,600)<br>4,725<br>59|
||||1,149,210|(1,366,315)|(217,105)|
|TOTAL FUNDS|||1,490,585|(1,557,930)|(67,345)|





## 

## 

||||Net|Transfers||
|---|---|---|---|---|---|
||||movement|between|At|
|||At I/1/20|in funds|funds|31/12/21|
|Unrestricted<br>funds||||||
|General fund||48,784|145,527|(194,311)||
|Restricted funds||||||
|Closure||45,000|(61,000)|16,000||
|Radiology Blastography|||(25,496)|25,496||
|Medical Photography||17||(17)||
|Microbiology<br>Maldi||42,646|(43,813)|1,167||
|Urology Prostate Fusion Sys||61,423|(50,000)|(11,423)||
|Colposcopy|||2,167|(2,167)||
|Advanced<br>Resus||27,207|(38,070)|10,863||
|Heart Andover 27k||9,588|(9,588)|||
|2020 Haemorrhoids|||(8,990)|8,990||
|2020 Vascular Ultrasound|||(21,306)|21,306||
|2020 Sleep Activity Monitor|||(367)|367||
|2020 Tissue Viability SEM Scanner|||15|(15)||
|2020 Feno Niox - Paediatrics|||95|(95)||
|2020 Patient Transfer Scale|||(40)|40||
|2020 Larynogograph|||(1,670)|1,670||
|2020 Iqoro Training Device|||(8,282)|8,282||
|2020 Neurotox|||179|(179)||
|2020 Airvo 2 Optiflow|||700|(700)||
|Luninometer<br>Pathology|||(4,378)|4,378||
|2020 Slide Scanner|||(66,725)|66,725||
|Baby Resus<br>Dig Deep Covid Emergency|Fund||(1,465)<br>(2,015)|1,465<br>2,015||
|2020 Biometry for Opthoamology|||(40,143)|40,143||
|||185,881|(380,192)|194,311||
|TOTAL FUNDS||234,665|(234,665)|||





## 

## 

|A current year 12 months<br>and prior year 12 months<br>as follows:|combined net movement<br>in f|unds,<br>included<br>in|the above<br>are|
|---|---|---|---|
||Incoming|Resources|Movement|
||resources|expended|in funds|
|||6||
|Unrestricted<br>funds<br>General fund|766,428|(620,901)|145,527|
|Restricted<br>funds<br>Closure<br>Radiology<br>Elastography<br>Microbiology<br>Maldi<br>Urology Prostate Fusion Sys<br>Colposcopy<br>Advanced<br>Resus<br>Heart Andover<br>271&<br>2020 Haemorrhoids<br>2020 Vascular Ultrasound<br>2020 Sleep Activity Monitor<br>2020 Tissue Viability SEM Scanner<br>2020 Droplet Hydration<br>System<br>2020 Feno Niox -Paediatrics<br>2020 Patient Transfer Scale<br>2020 Larynogograph<br>2020 Iqoro Training Device<br>2020 Neurotox<br>2020 Airvo 2 Optiflow<br>2020 Dri Oct Opthlmology<br>Luninometer<br>Pathology<br>HGF Fund<br>2020 Slide Scanner<br>Baby Resus<br>Dig Deep Covid Emergency<br>Fund<br>Andover|33,366<br>3,025<br>2,167<br>20,646<br>45<br>2,010<br>2,424<br>15<br>3,500<br>16,770<br>2,430<br>2,480<br>3,318<br>2,216<br>700<br>3,000<br>525<br>8,944<br>775<br>135<br>1,070,283<br>59|(61,000)<br>(58,862)<br>(46,838)<br>(50,000)<br>(58,716)<br>(9633)<br>(11,000)<br>(21,306)<br>(2,791)<br>(3,500)<br>(16,675)<br>(2,470)<br>(4,150)<br>(11,600)<br>(2,037)<br>(3,000)<br>(4,903)<br>(8,944)<br>(67,500)<br>(1,600)<br>(1,072,298)<br>(59)|(61,000)<br>(25,496)<br>(43,813)<br>(50,000)<br>2,167<br>(38,070)<br>(9,588)<br>(8,990)<br>(21,306)<br>(367)<br>15<br>95<br>(40)<br>(1,670)<br>(8,282)<br>179<br>700<br>(4,378)<br>(66,725)<br>(1,465)<br>(2,015)|
|2020 Biometry for Opthoamology<br>2020 Hologic Horizon Scanner<br>2021 Paceports|250<br>50,000<br>1,679|(40,393)<br>(50,000)<br>(1,679)|(40,143)|
||1,230,762|(1,610,954)|(380,192)|
|TOTAL FUNDS|1,997,190|(2,231,855)|(234,665)|





## 



## 

||||2021|2020|
|---|---|---|---|---|
||||6||
|INCOME AND ENDOWMENTS|||||
|Donations<br>and legacies|||||
|Donations|||149&015|1,242,616|
|Legacies|||227,461|2,079|
||||376&476|1,244,695|
|Other trading<br>activities|||||
|Fundraising<br>events|||130,001|245,651|
|Investment<br>income|||||
|Deposit account interest|||128|239|
|Total incoming<br>resources|||506,605|1,490,585|
|EXPENDITURE|||||
|Raising donations|and legacies||||
|Wages|||34)834|121,594|
|Event expenses|||8,521|30,347|
||||43,355|151,941|
|Charitable<br>activities|||||
|Medical equipment|costs||190|1,368,226|
|Grants to institutions|||615,767||
||||615)957|1,368,226|
|Support costs|||||
|Finance|||||
|Once costs|||9,637|21,984|
|Bank charges|||1,298|10,383|
|General expenses|||2,478|3,596|
||||13,413|35,963|
|Governance<br>costs|||||
|Independent<br>examiner's||fees|1,200|1,800|
|Total resources expended|||673,925|1,557,930|
|Net expenditure|||(167,320)|(67,345)|